| Samsung Bioepis CH GmbH - Imraldi 40 mg/0.4 ml, Injektionslösung in einer Fertigspritze |
| 67427 | | 02 | | Imraldi 40 mg/0.4 ml | | Injektionslösung in einer Fertigspritze | | L04AB04 | | Adalimumab | | 18.12.2024 | | |
|
| Composition |
| adalimumabum 40 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, acidum succinicum, dinatrii succinas, histidinum, histidini hydrochloridum monohydricum, mannitolum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.08 mg. |
| Packungsbestandteile |
| Solution injectable en seringue prête à l'emploi | | | | | | Principe actif | Concentr. |
|---|
| Adalimumab | 40mg / 0.4ml |
| | | | Agents auxilliaires |
|---|
| Acide Succinique | | Disodium Phosphate Heptahydrate | | Dinatrii Succinas | | Histidin Hydrochloride Monohydrate | | Histidine | | Mannitol | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 20 |
|
|
|
